XTX Topco’s Traws Pharma TRAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,210
Closed -$47.7K 4495
2025
Q4
$47.7K Buy
42,210
+31,502
+294% +$70.1K ﹤0.01% 2847
2025
Q3
$19.8K Buy
+10,708
New +$17.5K ﹤0.01% 2332

Other funds holding TRAW

XTX Topco's TRAW Position: Q1 2026 in Review

XTX Topco sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 42,210 shares — an estimated $47.7K sold.

XTX Topco first reported a position in TRAW in Q3 2025 and held it in 2 quarters. The position peaked at $47.7K in Q4 2025. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • XTX Topco reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 42,210 Traws Pharma shares in Q1 2026, an estimated $47.7K.
  • XTX Topco first reported a position in Traws Pharma in Q3 2025 and held it in 2 quarters.
  • XTX Topco's Traws Pharma position peaked at $47.7K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.